** Pharmaceuticals group HUTCHMED (China) 0013.HK jumps 10.7% to HK$26.45, highest since March 7
** Stock set for biggest one-day pct rise since March 13, 2024; third-biggest pct gainer on healthcare index .HSCIH, which is up 0.5%
** Co's 2024 net income attributable came in at $37.73 mln vs $100.78 mln in 2023
** Analysts on avg had forecast loss of $58.57 mln
** Jefferies ("buy") says co's FY24 profitability ahead of guidance
** YTD, stock up 16%
(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。